Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2238-2252
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2238
Table 1 Summary of reported proportion of cardia and non-cardia (including body and antrum) cancer worldwide
Region
Ref.
Period
Anatomical site ratio (%)1
Cardia
Non-Cardia
Body
Antrum
East AsiaNorthern ChinaThis article2014-201835.85%19.24%44.91%
Southwest ChinaLiu et al[19], 20162008-201237.15%10.30%52.55%
Northwest ChinaZhou et al[18], 20081993-200435.78%28.00%36.22%
JapanKoizumi et al[11], 20182013-20159.82%53.58%36.60%
West AsiaNorthwest IranDerakhshan et al[29], 20042000-200344.78%26.19%29.03%
North AmericaThe USACamargo et al[7], 20111999-200741.41%11.13%47.46%
EuropeCentral SwitzerlandSchmassmann et al[26], 20091982-200726.02%73.98%
SpainAragonés et al[27], 20101980-200426.67%73.33%
NetherlandHolster et al[28], 20141973-201131.82%30.30%37.88%
Table 2 Clinical and hospitalizing features on gastric cancer patients based on anatomic site subgroups
Variables


Cardia (n = 3673)
Body (n = 1972)
Antrum (n = 4602)
P value
Clinical featuresBasic informationGender< 0.001
Male3046 (82.93%)1264 (64.10%)3140 (68.23%)
Female627 (17.07%)708 (35.90%)1462 (31.77%)
Age (yr)< 0.001
≤ 49266 (7.24%)479 (24.29%)809 (17.58%)
50-74536 (78.16%)158 (67.70%)585 (69.71%)
≥ 752871 (14.60%)1335 (8.01%)3208 (12.71%)
Mean (mean ± SD)63.98 ± 10.21 (63.65, 64.31)57.57 ± 12.68 (57.04, 58.10)60.32 ± 12.06 (59.97, 60.67)< 0.001
Patient source< 0.001
Urban3000 (81.68%)1633 (82.81%)3969 (86.25%)
Rural673 (18.32%)339 (17.19%)633 (13.75%)
Insurance Source< 0.001
MIUE1499 (40.81%)906 (45.94%)2004 (43.55%)
MIUR179 (4.88%)98 (4.97%)205 (4.45%)
NRCMI673 (18.32%)302 (15.31%)627 (13.62%)
Own expense885 (24.09%)476 (24.14%)1121 (24.36%)
Others437 (11.90%)190 (9.64%)645 (14.02%)
ComplicationsHypertension< 0.001
No2630 (71.60%)1550 (78.60%)3470 (75.40%)
Yes1043 (28.40%)422 (21.40%)1132 (24.60%)
Diabetes0.03
No3213 (87.48%)1767 (89.60%)4093 (88.94%)
Yes460 (12.52%)205 (10.40%)509 (11.06%)
GERD< 0.001
No3252 (88.54%)1886 (95.64%)4387 (95.33%)
Yes421 (11.46%)86 (4.36%)215 (4.67%)
Cerebrovascular disease0.01
No3488 (94.96%)1895 (96.10%)4430 (96.26%)
Yes185 (5.04%)77 (3.90%)172 (3.74%)
Coronary disease< 0.001
No3353 (91.29%)1843 (93.46%)4309 (93.63%)
Yes320 (8.71%)129 (6.54%)293 (6.37%)
Obstruction< 0.001
No3616 (98.45%)1952 (98.99%)4136 (89.87%)
Yes57 (1.55%)20 (1.01%)466 (10.13%)
Anemia0.009
No3451 (93.96%)1811 (91.84%)4274 (92.87%)
Yes222 (6.04%)161 (8.16%)328 (7.13%)
Hypoproteinemia0.005
No3566 (97.09%)1882 (95.44%)4428 (96.22%)
Yes107 (2.91%)90 (4.56%)174 (3.78%)
Hospitalization featuresAdmission route0.007
Emergency100 (2.72%)28 (1.42%)101 (2.20%)
Non-emergency3573 (97.28%)1944 (98.58%)4501 (97.80%)
Stay (d) (mean ± SD)13.41 ± 12.17 (13.02, 13.80)14.08 ± 12.24 (13.57, 14.59)16.89 ± 12.24 (16.53, 17.24)< 0.001